7 recruiting, 5 completed, 5 not yet recruiting, 3 active not recruiting. 6 Not applicable, 3 Phase 4, 2 Phase 1, 1 Phase 2, 1 Phase 3.
Follow RSV: new trials by email Literature Review of RSV trials Research Report on RSV
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RSV Vaccination to Reduce Recurrent AECOPD RSV vaccination (Arexvy, GlaxoSmithKline) - COPD, RSV | Phase 4 | Not yet recruiting | Chinese University of Hong Kong | 320 | 2027-07-01 | 2026-04-13 |
| Usability and Clinical Validation of the Flu A/B/COVID-19 + RSV Multiplex Rapid Test Flu A/B/COVID-19 + RSV Multiplex Rapid Test - SARS-CoV-2 Infection, Influenza A | Not applicable | Not yet recruiting | CorDx, Inc. | 1500 | 2026-11-01 | 2026-10-15 |
| Immune Reponses to RSV B Challenge in Older Adults (A Controlled Human Infection Study With RSV in Older People-02) RSV B - RSV | Not applicable | Not yet recruiting | Imperial College London | 20 | 2026-08-01 | 2026-07-20 |
| A Phase 2 Study to Investigate the Efficacy and Safety of Zelicapavir in Participants Aged ≥28 Days to ≤36 Months of Age Infected With Respiratory Syncytial Virus zelicapavir, Placebo - RSV Infection, RSV | Phase 2 | Recruiting | Enanta Pharmaceuticals, Inc | 150 | 2026-07-09 | 2026-07-20 |
| Stakeholder-Informed RSV Prevention Economic Model in Botswana RSV | Active not recruiting | University of California, San Diego | 40 | 2026-07-01 | 2026-08-10 | |
| RSV Burden in Hong Kong Serial specimen sampling - RSV | Recruiting | Chinese University of Hong Kong | 10000 | 2026-03-24 | 2026-09-01 | |
| Study to Evaluate the Safety of a Lyophilized RSV mRNA Vaccine Low-dose RSV mRNA vaccine, High-dose RSV mRNA vaccine, Placebo - RSV, mRNA Vaccine | Phase 1 | Not yet recruiting | Sinovac Biotech Co., Ltd | 60 | 2026-03-09 | 2026-02-18 |
| The Role of Vitamin D and Vitamin D Receptor in Recurrent Wheezing in Children With Bronchiolitis: Immunological Association With T-lymphocyte Mitochondrial Mass No Intervention: Observational Cohort - Bronchiolitis Acute, Wheezing | Active not recruiting | National and Kapodistrian University of Athens | 130 | 2025-12-01 | 2026-07-13 | |
| Clinical Validation of the Aptitude Medical Systems Metrix Respiratory Panel Test in At-Home/Non-Laboratory Settings Aptitude Medical Systems Respiratory Panel Test - COVID -19, Influenza A | Not applicable | Not yet recruiting | Aptitude Medical Systems | 2000 | 2025-11-01 | 2025-10-16 |
| Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy Tdap Vaccine Administration, RSV Vaccine, Saline (as a placebo) - RSV, Tdap - Tetanus, Diphtheria and Acellular Pertussis Vaccination | Phase 4 | Recruiting | Canadian Immunization Research Network | 60 | 2025-10-16 | 2026-10-22 |
| Preparedness Through Respiratory Virus Epidemiology and Community Engagement Component A0, Component A1, Component A2 - Respiratory Infection Virus, COVID -19 | Recruiting | University of California, San Diego | 25000 | 2025-10-08 | 2025-11-04 | |
| Surveillance, Assessment and Detection of Influenza Associated Respiratory Infections in HIV Positive and Negative Individual in Lusaka, Zambia. Influenza, RSV | Recruiting | Centre for Infectious Disease Research in Zambia | 594 | 2025-05-20 | 2026-08-05 | |
| Vaccine Effectiveness of a Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing RSV Hospitalizations in Adults RSV prefusion F protein-based vaccine - RSV | Phase 4 | Active not recruiting | Tor Biering-Sørensen | 690000 | 2024-11-18 | 2026-05-29 |
| Covid Flu A/B and RSV 4 in 1 Diagnostic Test Investigational Flu A/B Covid-19 and RSV Diagnostic Test - Influenza A, Influenza B | Completed | iHealth Labs inc | 1119 | 2024-11-15 | 2026-01-08 | |
| Clinical Evaluation of the VitaSIRO Solo™ Respiratory Assay Credo POCT Device - SARS-CoV-2, COVID-19 | Completed | Credo Diagnostics Biomedical Pte. Ltd. | 1268 | 2024-11-01 | 2026-03-18 | |
| A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients LIAISON NES FLU A/B, RSV & COVID-19 - Influenza a, Influenza B | Not applicable | Recruiting | DiaSorin Molecular LLC | 1000 | 2024-09-30 | 2024-11-04 |
| Effectiveness And Impact Of Nirsevimab In Chile (NIRSE-CL) Nirsevimab - RSV | Unknown | Instituto Sistemas Complejos de Ingeniería | 160000 | 2024-04-01 | 2024-07-22 | |
| A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years Old mRNA-1010, mRNA-1345, mRNA-1273.214 - SARS-CoV-2, Influenza | Phase 1 | Completed | ModernaTX, Inc. | 392 | 2022-10-14 | 2024-03-08 |
| Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA) COVID-19, SARS-CoV-2 Infection, RSV | Recruiting | VA Office of Research and Development | 400000 | 2022-09-26 | 2026-09-30 | |
| Clinical Lot Consistency for RSVpreF in a Population of Healthy Adults 18 to ≤49 Years of Age RSVpreF (Group 1), RSVpreF (Group 2), RSVpreF (Group 3) - RSV | Phase 3 | Completed | Pfizer | 1028 | 2021-10-21 | 2023-04-12 |
Showing 20 of 22. Sign in to see all of them.
COVID-19 (9) · Influenza, Human (5) · Bronchiolitis (1) · Coronavirus Infections (1) · Diphtheria (1) · Premature Birth (1) · Pulmonary Disease, Chronic Obstructive (1) · Respiratory Sounds (1) · Respiratory Syncytial Virus Infections (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1) · Virus Diseases (1)
Infections (13) · Respiratory Tract Diseases (12) · Lung Diseases (11) · RNA Virus Infections (11) · Respiratory Tract Infections (10) · Virus Diseases (10) · Coronaviridae Infections (9) · Nidovirales Infections (9) · Pneumonia (9) · Pneumonia, Viral (9) · Coronavirus Infections (8) · Orthomyxoviridae Infections (5) · Lung Diseases, Obstructive (2) · Pathological Conditions, Signs and Symptoms (2) · Actinomycetales Infections (1)
Boostrix (1) · Early Intervention, Educational (1) · Respiratory Syncytial Virus Vaccines (1) · Saline Solution (1) · Sodium Chloride (1) · abrysvo (1) · arexvy (1) · halofantrine (1) · mRNA-1010 influenza vaccine (1) · mRNA-1273.214 COVID-19 vaccine (1) · mRNA-1345 respiratory syncytial virus vaccine (1) · nirsevimab (1)
Chinese University of Hong Kong (2) · University of California, San Diego (2) · Aptitude Medical Systems (1) · Canadian Immunization Research Network (1) · Centre for Infectious Disease Research in Zambia (1) · CorDx, Inc. (1) · Credo Diagnostics Biomedical Pte. Ltd. (1) · DiaSorin Molecular LLC (1) · Enanta Pharmaceuticals, Inc (1) · Imperial College London (1) · Instituto Sistemas Complejos de Ingeniería (1) · Kosuyolu Heart Hospital (1) · ModernaTX, Inc. (1) · National and Kapodistrian University of Athens (1) · Pfizer (1)
United States (8) · Hong Kong (2) · Australia (1) · Botswana (1) · Canada (1) · Chile (1) · China (1) · Denmark (1) · Greece (1) · Israel (1) · Puerto Rico (1) · Spain (1) · Taiwan (1) · Thailand (1) · Turkey (Türkiye) (1)
Bahaa Abu-Raya, M.D., PhD (1) · Brad W Killingsworth, M.A. (1) · Christopher Chiu, BMBCh FRCP FRCPath PhD (1) · David SC Hui, MD (1) · Elif Erolu, M.D.Ph.D. (1) · George N. Ioannou, MD MS (1) · Kristina L Bajema, MD (1) · Tania Siahanidou, Professor (1)
PMID 38616438, PMID 38664919, PMID 40028879, PMID 40513593, PMID 40738309, PMID 40884493, PMID 40888695, PMID 42666088, PMID 42666095, PMID 42702887